The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional) |
93.279 |
RFA-DA-22-009 |
| PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) |
93.279 |
RFA-DA-22-017 |
| Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) |
93.853, 93.866 |
RFA-AG-22-017 |
| Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional) |
93.242, 93.279, 93.855 |
RFA-AI-20-069 |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) |
93.213 |
PAR-21-241 |
| Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) |
93.846, 93.855 |
PAS-21-245 |
| Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) |
93.213 |
PAR-21-242 |
| Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) |
93.213 |
PAR-21-243 |
| DOD Kidney Cancer, Clinical Trial Award |
12.420 |
W81XWH-21-KCRP-CTA |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) |
93.213 |
PAR-21-240 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-003 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) |
93.866 |
RFA-AG-22-007 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-004 |
| NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) |
93.279 |
PAR-21-244 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) |
93.866 |
RFA-AG-22-014 |
| Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-046 |
| High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-019 |
| BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866 |
RFA-NS-21-026 |
| BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866 |
RFA-NS-21-027 |
| Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-023 |
| HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) |
93.121, 93.213, 93.242, 93.273, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-029 |
| Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed) |
93.855 |
PAR-21-257 |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional) |
93.273, 93.279 |
RFA-AA-21-008 |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) |
93.310 |
RFA-RM-21-017 |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional) |
93.273, 93.279 |
RFA-AA-21-007 |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) |
93.273, 93.279 |
RFA-AA-21-009 |
| Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed) |
93.279 |
RFA-DA-22-016 |
| Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.397, 93.399 |
PAR-21-138 |
| Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed) |
93.172 |
RFA-HG-21-026 |
| Characterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 Diabetes (R01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-016 |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional) |
93.273 |
RFA-AA-21-010 |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Resource (U24) (Clinical Trial Not Allowed) |
93.273 |
RFA-AA-21-011 |
| Advancing Novel Medical Isotopes for Clinical Trials |
81.049 |
DE-FOA-0002532 |
| The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) |
93.393, 93.394 |
RFA-CA-21-035 |
| The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-21-034 |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Resource (U24 Clinical Trial Not Allowed) |
93.273 |
RFA-AA-21-013 |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional) |
93.273 |
RFA-AA-21-014 |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Resource (U24 Clinical Trial Not Allowed) |
93.273 |
RFA-AA-21-012 |
| The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) |
93.394 |
RFA-CA-21-033 |
| NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) |
93.866 |
PAR-21-218 |
Search Results 2041-2080 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
